Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Debt to Equity (2018 - 2025)

Exagen (XGN) has disclosed Debt to Equity for 8 consecutive years, with $1.31 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 38.14% year-over-year to $1.31, compared with a TTM value of $1.31 through Dec 2025, down 38.14%, and an annual FY2025 reading of $1.31, down 38.14% over the prior year.
  • Debt to Equity was $1.31 for Q4 2025 at Exagen, up from $1.26 in the prior quarter.
  • Across five years, Debt to Equity topped out at $3.27 in Q1 2025 and bottomed at $0.26 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.95, with a median of $0.76 recorded in 2023.
  • The sharpest move saw Debt to Equity crashed 49.48% in 2021, then soared 234.63% in 2025.
  • Year by year, Debt to Equity stood at $0.32 in 2021, then surged by 110.88% to $0.68 in 2022, then rose by 25.91% to $0.86 in 2023, then skyrocketed by 147.03% to $2.12 in 2024, then crashed by 38.14% to $1.31 in 2025.
  • Business Quant data shows Debt to Equity for XGN at $1.31 in Q4 2025, $1.26 in Q3 2025, and $1.09 in Q2 2025.